Author: Michael

South Korean RNA-editing firm enters Eli Lilly’s San Diego innovation hub to speed its precision gene-therapy pipeline toward the clinic. Biotech real estate has its own hierarchy, and San Diego sits near the top. So when a Seongnam-based RNA therapeutics company buys itself a desk inside Eli Lilly’s newest innovation outpost there, it’s worth asking what that access is actually worth and whether it says more about the company or about Lilly’s appetite for outside science. Rznomics Inc announced that it is joining Lilly Gateway Labs (LGL), the pharma giant’s San Diego hub for biotech companies working alongside its scientists…

Read More